← Back to Nuqta Atlas
Editorially curated · qa-national-sars-cov2-sequencing
Qatar National SARS-CoV-2 Sequencing Effort
National viral sequencing and variant analysis supporting outbreak reconstruction, variant monitoring, and policy during the COVID-19 pandemic.
01 / Project overview
What the record establishes.
- Geographic scope
- National
- Project type
- pathogen genomic surveillance
- Research domain
- infectious disease genomics and public health
- Years
- 2020–2022
- Lifecycle status
- completed pandemic-scale sequencing; laboratory capacity retained
- Status basis
- Qatar University's current BRC facility account credits the center with leading national sequencing of more than 8,000 samples and sharing sequences with public databases and authorities.
- Status evidence date
- 2026-08-15
- Scale
- More than 8,000 samples sequenced by the BRC; a major 2021 national variant survey separately analyzed 9,792 PCR-genotyped samples.
02 / Organizations and population
Who and what the project connects.
- Lead organizations
- Qatar University Biomedical Research Center
- Partner organizations
- Ministry of Public Health · Hamad Medical Corporation · Weill Cornell Medicine-Qatar
- Organism / population
- SARS-CoV-2-positive clinical samples in Qatar
03 / Data and access
What exists and how it can be reached.
Data types
- viral whole-genome sequencing
- variant genotyping
- phylogenetics
- epidemiological metadata
Data access
Selected sequences public in NCBI/GISAID; aggregate analyses in publications.
Identifiers
- BioProject
PRJNA707370
04 / Evidence and provenance
Why the record is included.
Inclusion basis
National, multi-thousand-sample pathogen-genomics effort with public sequence deposition.
Editorial note
Sequence and PCR-genotype totals reflect different overlapping analyses and should not be added.
Sources
- primary record source Verified 2026-08-15
- additional record source Verified 2026-08-15
- additional record source Verified 2026-08-15
Release v0.2.0